Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	179.15	270.15	276.11	523.49	1,161	382.62
Short-Term Investments	-	601.14	50	50.95	-	-
Trading Asset Securities	558.55	201.51	280.02	888.68	927.45	-
Cash & Short-Term Investments	737.7	1,073	606.13	1,463	2,089	382.62
Cash Growth	-8.30%	76.99%	-58.57%	-29.94%	445.84%	-9.51%
Accounts Receivable	117.7	92.49	28.59	102.04	38.21	29.13
Other Receivables	3.34	24.13	28.93	17.01	47.36	2.54
Receivables	121.04	116.62	57.52	119.06	85.57	31.68
Inventory	80.36	83.45	137.21	154.25	258.62	126.31
Prepaid Expenses	-	-	0.15	2.6	-	-
Other Current Assets	530.69	19.55	38.9	59.24	84.98	47.16
Total Current Assets	1,470	1,292	839.91	1,798	2,518	587.77
Property, Plant & Equipment	1,047	1,074	1,193	867.94	562.12	237.38
Long-Term Investments	443.43	826.04	1,418	1,038	441.6	-
Other Intangible Assets	51.17	52.12	55.07	56.55	57.33	58.45
Long-Term Deferred Tax Assets	27.13	26.64	34.4	38.8	15.95	3.15
Long-Term Deferred Charges	24.06	25.55	24.3	23.2	22.32	10.56
Other Long-Term Assets	209.28	29.3	6.76	76.21	27.85	5.21
Total Assets	3,272	3,326	3,572	3,899	3,645	902.52
Accounts Payable	139.83	46.12	44.72	151.52	141.27	66.24
Accrued Expenses	15.67	30.23	25.55	177.68	167.53	36.63
Short-Term Debt	50	-	-	-	-	-
Current Portion of Leases	0.11	0.12	7.49	27.95	13	-
Current Income Taxes Payable	6.29	1.06	1.15	1.13	120.24	16.7
Current Unearned Revenue	13.95	16.7	28.08	56.98	267.05	12.71
Other Current Liabilities	47.62	141.66	81.05	96.06	25.08	11.84
Total Current Liabilities	273.47	235.89	188.04	511.31	734.16	144.11
Long-Term Leases	0.12	0.12	7.76	14.18	22.98	-
Long-Term Unearned Revenue	16.07	15.75	9.77	10.77	9.47	9.61
Long-Term Deferred Tax Liabilities	-	-	-	9.32	4.41	2
Total Liabilities	289.67	251.77	205.57	545.59	771.01	155.72
Common Stock	92.47	92.47	92.27	92.05	62.2	62.2
Additional Paid-In Capital	325.13	321.41	444.04	435.31	458.31	449.85
Retained Earnings	2,762	2,786	2,994	2,958	2,323	230.85
Treasury Stock	-205.32	-133.89	-166.48	-150.04	-	-
Comprehensive Income & Other	10.27	9.96	4.32	-0.03	-0.3	-0.16
Total Common Equity	2,984	3,076	3,368	3,335	2,844	742.73
Minority Interest	-1.99	-1.43	-2.12	18.46	30.31	4.06
Shareholders' Equity	2,982	3,074	3,366	3,354	2,874	746.79
Total Liabilities & Equity	3,272	3,326	3,572	3,899	3,645	902.52
Total Debt	50.23	0.24	15.26	42.13	35.98	-
Net Cash (Debt)	687.47	1,073	590.87	1,421	2,053	382.62
Net Cash Growth	-13.59%	81.52%	-58.42%	-30.77%	436.43%	-4.13%
Net Cash Per Share	7.28	11.61	6.69	15.46	22.30	4.15
Filing Date Shares Outstanding	88.6	89.58	89.41	89.53	92.05	92.05
Total Common Shares Outstanding	88.6	89.58	89.41	89.53	92.05	92.05
Working Capital	1,196	1,057	651.88	1,287	1,784	443.66
Book Value Per Share	33.68	34.33	37.67	37.25	30.89	8.07
Tangible Book Value	2,933	3,023	3,313	3,279	2,786	684.28
Tangible Book Value Per Share	33.10	33.75	37.06	36.62	30.27	7.43
Buildings	-	703.6	704.79	174.55	162.16	55.38
Machinery	-	567.73	575.66	399.88	317.94	196.3
Construction In Progress	-	5.62	48.18	374.44	121.71	55.45

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.